|
1
|
Olusola P, Banerjee HN, Philley JV and
Dasgupta S: Human papilloma virus-associated cervical cancer and
health disparities. Cells. 8:6222019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Vu M, Yu J, Awolude OA and Chuang L:
Cervical cancer worldwide. Curr Probl Cancer. 42:457–465. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cohen PA, Jhingran A, Oaknin A and Denny
L: Cervical cancer. Lancet. 393:169–182. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mei D, Zhu Y, Zhang L and Wei W: The Role
of CTHRC1 in regulation of multiple signaling and tumor progression
and metastasis. Mediators Inflamm. 2020:95787012020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zagorska A, Deak M, Campbell DG, Banerjee
S, Hirano M, Aizawa S, Prescott AR and Alessi DR: New roles for the
LKB1-NUAK pathway in controlling myosin phosphatase complexes and
cell adhesion. Sci Signal. 3:ra252010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bright NJ, Thornton C and Carling D: The
regulation and function of mammalian AMPK-related kinases. Acta
Physiol (Oxf). 196:15–26. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sun X, Gao L, Chien HY, Li WC and Zhao J:
The regulation and function of the NUAK family. J Mol Endocrinol.
51:R15–R22. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tang L, Tong SJ, Zhan Z, Wang Q, Tian Y
and Chen F: Expression of NUAK2 in gastric cancer tissue and its
effects on the proliferation of gastric cancer cells. Exp Ther Med.
13:676–680. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fu TG, Wang L, Li W, Li JZ and Li J:
miR-143 inhibits oncogenic traits by degrading NUAK2 in
glioblastoma. Int J Mol Med. 37:1627–1635. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang Y, Lee Y and Han K: Neuronal
function and dysfunction of CYFIP2: From actin dynamics to early
infantile epileptic encephalopathy. BMB Rep. 52:304–311. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jiao S, Li N, Cai S, Guo H and Wen Y:
Inhibition of CYFIP2 promotes gastric cancer cell proliferation and
chemoresistance to 5-fluorouracil through activation of the Akt
signaling pathway. Oncol Lett. 13:2133–2140. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jackson RS II, Cho YJ, Stein S and Liang
P: CYFIP2, a direct p53 target, is leptomycin-B sensitive. Cell
Cycle. 6:95–103. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
von Mering C, Huynen M, Jaeggi D, Schmidt
S, Bork P and Sne B: STRING: A database of predicted functional
associations between proteins. Nucleic Acids Res. 31:258–261. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chandrashekar DS, Bashel B, Balasubramanya
SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK and
Varambally S: UALCAN: A portal for facilitating tumor subgroup gene
expression and survival analyses. Neoplasia. 19:649–658. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hung P, Zahnd WE, Brandt HM, Adams SA,
Wang S and Eberth JM: Cervical cancer treatment initiation and
survival: The role of residential proximity to cancer care. Gynecol
Oncol. 160:219–226. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Namiki T, Yaguchi T, Nakamura K, Valencia
JC, Coelho SG, Yin L, Kawaguchi M, Vieira WD, Kaneko Y, Tanemura A,
et al: NUAK2 amplification coupled with PTEN deficiency promotes
melanoma development via CDK activation. Cancer Res. 75:2708–2715.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Namiki T, Tanemura A, Valencia JC, Coelho
SG, Passeron T, Kawaguchi M, Vieira WD, Ishikawa M, Nishijima W,
Izumo T, et al: AMP kinase-related kinase NUAK2 affects tumor
growth, migration, and clinical outcome of human melanoma. Proc
Natl Acad Sci USA. 108:6597–6602. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Emmanuel C, Gava N, Kennedy C, Balleine
RL, Sharma R, Wain G, Brand A, Hogg R, Etemadmoghadam D, George J,
et al: Comparison of expression profiles in ovarian epithelium in
vivo and ovarian cancer identifies novel candidate genes involved
in disease pathogenesis. PLoS One. 6:e176172011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen JH, Tarry-Adkins JL, Matharu K, Yeo
GS and Ozanne SE: Maternal protein restriction affects gene
expression profiles in the kidney at weaning with implications for
the regulation of renal function and lifespan. Clin Sci (Lond).
119:373–384. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Aiello NM and Kang Y: Context-dependent
EMT programs in cancer metastasis. J Exp Med. 216:1016–1026. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zweier M, Begemann A, McWalter K, Cho MT,
Abela L, Banka S, Behring B, Berger A, Brown CW, Carneiro M, et al:
Spatially clustering de novo variants in CYFIP2, encoding the
cytoplasmic FMRP interacting protein 2, cause intellectual
disability and seizures. Eur J Hum Genet. 27:747–759. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tiwari SS, Mizuno K, Ghosh A, Aziz W,
Troakes C, Daoud J, Golash V, Noble W, Hortobágyi T and Giese KP:
Alzheimer-related decrease in CYFIP2 links amyloid production to
tau hyperphosphorylation and memory loss. Brain. 139:2751–2765.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chang YS, Huang HD, Yeh KT and Chang JG:
Identification of novel mutations in endometrial cancer patients by
whole-exome sequencing. Int J Oncol. 50:1778–1784. 2017. View Article : Google Scholar : PubMed/NCBI
|
